Business Description
Quest PharmaTech Inc
NAICS : 325412
SIC : 3741
ISIN : CA74836M1068
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.98 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 18.4 | |||||
3-Year EPS without NRI Growth Rate | 17.4 | |||||
3-Year FCF Growth Rate | 57.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 17.67 | |||||
9-Day RSI | 31.45 | |||||
14-Day RSI | 38.04 | |||||
6-1 Month Momentum % | -50 | |||||
12-1 Month Momentum % | -60 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.26 | |||||
Quick Ratio | 0.26 | |||||
Cash Ratio | 0.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -2.08 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -28.96 | |||||
ROA % | -28.56 | |||||
ROIC % | -1.51 | |||||
ROC (Joel Greenblatt) % | -23408.42 | |||||
ROCE % | -28.94 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 0.5 | |||||
PB Ratio | 0.05 | |||||
Price-to-Tangible-Book | 0.05 | |||||
EV-to-EBIT | -0.19 | |||||
EV-to-EBITDA | -0.19 | |||||
EV-to-FCF | -8.99 | |||||
Price-to-Projected-FCF | 0.14 | |||||
Earnings Yield (Greenblatt) % | -526.32 | |||||
FCF Yield % | -14.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Quest PharmaTech Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.123 | ||
Beta | -0.5 | ||
Volatility % | 79.66 | ||
14-Day RSI | 38.04 | ||
14-Day ATR (C$) | 0.002184 | ||
20-Day SMA (C$) | 0.025 | ||
12-1 Month Momentum % | -60 | ||
52-Week Range (C$) | 0.02 - 0.105 | ||
Shares Outstanding (Mil) | 169.13 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Quest PharmaTech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Quest PharmaTech Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Quest PharmaTech Inc Frequently Asked Questions
What is Quest PharmaTech Inc(TSXV:QPT)'s stock price today?
When is next earnings date of Quest PharmaTech Inc(TSXV:QPT)?
Does Quest PharmaTech Inc(TSXV:QPT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |